Study guide
17.4 Neuromuscular Disorders & Headache
Arab Board Pediatrics Part 1 Written Examination ABHS
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current ABHS Pediatrics Part 1 Exam Facts 1.2 How to Use This Guide & Part 1 Study Strategy
2 Neonatal Care I
2.1 Delivery-Room Management & Neonatal Resuscitation 2.2 Prematurity & Complications of Prematurity 2.3 Neonatal Jaundice & Hyperbilirubinemia
3 Neonatal Care II
3.1 Neonatal Sepsis & Infections 3.2 Neonatal Hypoglycemia & Metabolic Problems 3.3 Common Newborn Problems, Birth Injury & Screening
4 Infectious Diseases
4.1 Fever Without a Source & Sepsis Evaluation 4.2 Viral Exanthems & Common Childhood Infections 4.3 TORCH & Congenital Infections 4.4 Tuberculosis & Chronic/Unusual Pediatric Infections
5 Immunization
5.1 Routine Immunization Schedule & Vaccine Science 5.2 Contraindications, Adverse Events & Special Populations
6 Allergy & Immunology
6.1 Primary Immunodeficiency 6.2 Allergic Disease & Atopy
7 Growth & Development
7.1 Developmental Milestones & Red Flags 7.2 Growth Assessment & Failure to Thrive 7.3 Corrected Age & Preterm Follow-Up 7.4 Developmental & Behavioral Disorders
8 Nutrition
8.1 Breastfeeding & Infant Feeding 8.2 Weaning & Malnutrition 8.3 Micronutrient Deficiencies (Rickets, Iron Deficiency)
9 Pediatric Emergencies I
9.1 Pediatric Basic & Advanced Life Support 9.2 Anaphylaxis & Allergic Emergencies 9.3 Poisoning & Toxicology
10 Pediatric Emergencies II
10.1 Septic Shock & the Critically Ill Child 10.2 Upper Airway Emergencies (Epiglottitis, Foreign Body) 10.3 Non-Accidental Injury & Safeguarding
11 Cardiology
11.1 Cyanotic Congenital Heart Disease 11.2 Acyanotic Congenital Heart Disease & Heart Failure 11.3 Innocent Murmurs & Cardiac Evaluation 11.4 Rheumatic Fever & Acquired Heart Disease
12 Respiratory
12.1 Asthma 12.2 Bronchiolitis & Croup 12.3 Foreign Body Aspiration & Other Airway Disorders
13 Gastroenterology
13.1 Pyloric Stenosis & Vomiting Disorders 13.2 Intussusception & the Surgical Abdomen 13.3 Celiac Disease & Malabsorption 13.4 Hirschsprung Disease & Biliary Atresia
14 Nephrology & Genitourinary
14.1 Nephrotic Syndrome 14.2 Glomerulonephritis & Hematuria 14.3 UTI, Enuresis & Genitourinary Anomalies
15 Hematology & Oncology
15.1 Pediatric Anemias (Iron Deficiency, Thalassemia) 15.2 Sickle Cell Disease 15.3 Leukemia & Childhood Malignancies (incl. Wilms Tumor) 15.4 Bleeding & Platelet Disorders (ITP) & G6PD Deficiency
16 Endocrinology
16.1 Diabetes Mellitus & Diabetic Ketoacidosis 16.2 Thyroid & Adrenal Disorders 16.3 Growth Disorders & Puberty
17 Neurology
17.1 Febrile Seizures 17.2 Epilepsy Syndromes & Status Epilepticus 17.3 Bacterial Meningitis & CNS Infections 17.4 Neuromuscular Disorders & Headache
18 Genetics, Dysmorphology & Metabolism
18.1 Chromosomal Disorders & Dysmorphology 18.2 Inheritance Patterns, Consanguinity & Inborn Errors of Metabolism
19 Fluids, Electrolytes & Pharmacology
19.1 Maintenance Fluids & Dehydration 19.2 Electrolyte Disturbances 19.3 Pediatric Pharmacology & Prescribing/Dosing
20 Dermatology, ENT, Ophthalmology & Musculoskeletal
20.1 Common Pediatric Dermatology 20.2 ENT Disorders 20.3 Ophthalmology (Strabismus, Red Eye, Leukocoria) 20.4 Musculoskeletal & Rheumatologic Disorders
21 Adolescent Medicine & Ethics
21.1 Adolescent Health & Puberty 21.2 Ethics, Consent & Professionalism in Pediatrics
22 Final Review & Exam Strategy
22.1 High-Yield Numbers, Mnemonics & Cross-Topic Review 22.2 Exam-Day Strategy & Time Management
17.4 Neuromuscular Disorders & Headache
Key Takeaways Explain This Topic AI
Duchenne muscular dystrophy is X-linked recessive, presents with Gowers sign and calf pseudohypertrophy, and shows markedly elevated CK confirmed by dystrophin gene testing.
Spinal muscular atrophy is autosomal recessive (SMN1 gene deletion), causing symmetric proximal weakness, areflexia, and tongue fasciculations with preserved cognition; disease-modifying therapies have transformed the historically fatal Type 1 prognosis.
Guillain-Barre syndrome causes post-infectious ascending weakness with areflexia and CSF albuminocytologic dissociation (elevated protein, normal cell count); IVIG or plasmapheresis are the treatments of choice, and corticosteroids are not effective.
Most pediatric headaches are primary (migraine or tension-type) and do not require imaging; red flags such as early-morning headache with vomiting, Valsalva-triggered pain, papilledema, or focal deficits warrant urgent MRI.
Respiratory and autonomic monitoring are essential in Guillain-Barre syndrome, because respiratory muscle failure, not limb weakness, is the primary life-threatening complication.
Last updated: July 2026
Neuromuscular Disorders & Headache
This section pairs two exam staples: the major pediatric neuromuscular disorders, distinguished largely by the pattern of weakness, inheritance, and key bedside or laboratory clues, and the approach to pediatric headache, which mirrors the red-flag reasoning already introduced for febrile seizures and meningitis.
Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by mutations in the dystrophin gene on the X chromosome, so it affects boys almost exclusively. About one-third of cases arise from new (de novo) mutations rather than maternal carrier inheritance, a detail the exam likes to use as a trap in a stem with a negative family history.
Onset: typically ages 2-5 years, with delayed walking, a waddling gait, frequent falls, and difficulty climbing stairs or rising from the floor
Gowers sign: when asked to rise from a seated or lying position on the floor, the child uses their hands to walk up their own thighs and legs to compensate for weak proximal hip and thigh extensor muscles; this is one of the single most recognizable exam findings in pediatrics
Calf pseudohypertrophy: the calves appear enlarged but are firm, because fatty and fibrous tissue is replacing degenerating muscle rather than true muscle bulk
Creatine kinase (CK): markedly elevated, often 10-100 times the upper limit of normal, and elevated even before overt clinical weakness; an incidentally very high CK in a young boy, discovered on labs drawn for another reason, should trigger a DMD workup
Diagnosis: confirmed by genetic testing for a dystrophin gene deletion or duplication, which identifies the mutation in most cases; muscle biopsy showing absent dystrophin on immunohistochemistry is reserved for cases where genetic testing is inconclusive
Course: progressive proximal weakness, with loss of independent ambulation typically by age 10-13, followed by cardiomyopathy and respiratory muscle failure; corticosteroids (prednisone or deflazacort) are the mainstay treatment to slow progression, and newer exon-skipping or gene-targeted therapies apply to specific mutation subsets
Becker muscular dystrophy is the milder allelic counterpart of DMD: later onset, slower progression, and partially functional rather than absent dystrophin. It is a common distractor answer against DMD on exam stems.
Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by deletion or mutation of the SMN1 gene on chromosome 5, leading to progressive degeneration of anterior horn cells (lower motor neurons) in the spinal cord. Because this is a pure lower motor neuron disease, the exam-defining clue is symmetric proximal weakness with hypotonia, areflexia, and tongue fasciculations, but entirely preserved cognition.
Type Onset Milestone ceiling Historical course
Type 1 (Werdnig-Hoffmann) Younger than 6 months Never achieves independent sitting Most severe; without treatment, respiratory failure typically by age 2
- Type 2 6-18 months Sits independently, never walks unsupported Intermediate severity
- Type 3 (Kugelberg-Welander) After 18 months Achieves independent ambulation Mildest, slower progression
SMA is now included in newborn screening programs in many countries, because early treatment dramatically changes outcomes. Disease-modifying therapies, including nusinersen (an intrathecal antisense oligonucleotide), onasemnogene abeparvovec (a one-time intravenous gene replacement therapy), and risdiplam (an oral SMN2 splicing modifier), have transformed what was historically a uniformly fatal Type 1 course into a much more favorable prognosis when treatment is started early.
Guillain-Barre Syndrome
Guillain-Barre syndrome (GBS) is an acute inflammatory demyelinating polyneuropathy, typically post-infectious, occurring 1-3 weeks after a gastrointestinal illness (classically Campylobacter jejuni ) or a nonspecific upper respiratory infection.
Ascending weakness: symmetric weakness that begins distally in the legs and progresses upward, potentially involving the trunk, arms, and cranial nerves, with facial diplegia being common
Areflexia or hyporeflexia: loss of deep tendon reflexes is a hallmark finding and helps distinguish GBS from central causes of weakness
Sensory symptoms, such as paresthesias and pain, are often present subjectively, but objective sensory loss on exam is usually mild relative to the degree of motor weakness
Autonomic instability (labile blood pressure, arrhythmia) and respiratory muscle weakness are the two features that make GBS dangerous; vital capacity and negative inspiratory force should be monitored serially, since a child can progress to needing mechanical ventilation
Cerebrospinal fluid (CSF): the classic finding is albuminocytologic dissociation, meaning elevated protein with a normal white cell count; this finding may be absent in the first week of illness, so a normal CSF early on does not rule out GBS
Treatment: intravenous immunoglobulin (IVIG) or plasmapheresis are equally effective; corticosteroids are not effective in GBS, a frequently tested negative
A classic exam differentiator: myasthenia gravis causes fatigable weakness without sensory symptoms or areflexia; botulism causes a descending paralysis with early autonomic findings and normal or preserved early reflexes; transverse myelitis produces a sensory level and bowel or bladder dysfunction. GBS is distinguished by its ascending pattern, areflexia, and albuminocytologic dissociation together.
Pediatric Headache: Primary vs. Red-Flag Secondary Features
Most children presenting with headache have a primary headache disorder, migraine or tension-type headache, and do not need neuroimaging. Pediatric migraine differs slightly from the adult pattern: it is often shorter in duration, sometimes as brief as 1-2 hours compared with the adult criterion of 4 hours or longer, and more frequently bilateral rather than strictly unilateral.
The exam expects recognition of red flags that warrant neuroimaging to exclude a secondary cause, such as a mass lesion, hydrocephalus, or vascular event:
Worst headache of life, or thunderclap onset with sudden, maximal-intensity pain
Headache that wakes the child from sleep, or is worse in the early morning with vomiting, the classic pattern of raised intracranial pressure from a posterior fossa tumor
- Progressive increase in frequency or severity over weeks
- Focal neurologic signs, ataxia, or a new cranial nerve palsy
- Papilledema on fundoscopic exam
Headache triggered or worsened by Valsalva maneuvers such as coughing, straining, or bending over, suggesting a Chiari malformation or posterior fossa mass
Change in personality, decline in school performance, or abnormal growth and endocrine findings, suggesting a lesion in the hypothalamic-pituitary region
Fever with neck stiffness, suggesting meningitis (see section 17.3)
Very young age, roughly under 3-6 years, with a new headache, since younger children have a higher pretest probability of an underlying secondary cause
A new or changed headache pattern in a child with a ventriculoperitoneal (VP) shunt, raising concern for shunt malfunction, or in a child with neurofibromatosis type 1 or tuberous sclerosis, both of which carry elevated tumor risk
The decision logic tested on this exam is straightforward: a child whose headache history and exam are reassuring, with a normal neurologic exam, no red flags, and a family history of migraine, needs clinical diagnosis and headache-specific management rather than imaging. Any red flag above shifts the answer toward urgent magnetic resonance imaging (MRI) of the brain, which is preferred over computed tomography (CT) when the situation is not emergent, in order to avoid radiation exposure and better visualize the posterior fossa.